Publication: Magyar Közlöny
Issue: MK-2009-195 (Year: 2009, Number: 195)
Era: 2004-2010
Section: A Kormány a 99/2007. (V. 8.) Korm. rendelettel kihirdetett, a sportbeli dopping elleni nemzetközi egyezmény
Paragraph Index: 18

6. Platelet-derived preparations (e.g. Platelet Rich Plasma, “blood spinning”) administered by intramuscular route. Other routes of administration require a declaration of Use in accordance with the International Standard for Therapeutic Use Exemptions. and other substances with similar chemical structure or similar biological effect(s). S3. BETA-2 AGONISTS All beta-2 agonists (including both optical isomers where relevant) are prohibited except salbutamol (maximum 1600 micrograms over 24 hours) and salmeterol by inhalation which require a declaration of Use in accordance with the International Standard for Therapeutic Use Exemptions. The presence of salbutamol in urine in excess of 1000 ng/mL is presumed not to be an intended therapeutic use of the substance and will be considered as an Adverse Analytical Finding unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of the use of a therapeutic dose (maximum 1600 micrograms over 24 hours) of inhaled salbutamol. S4. HORMONE ANTAGONISTS AND MODULATORS The following classes are prohibited:

Source: https://magyarkozlony.hu/hivatalos-lapok/23f07f654cf53636d7b859fa6653684c851ff3b3/dokumentumok/738eac03c9f6a15eb346ef7dd1f0848b3d00bbe8/letoltes